Skip to main content

COVID 19 Updates from RheumNow

Telemedicine Less Utilized in the South and Urban Areas

MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.

Plaquenil Does Not Protect Lupus Patients from COVID-19 (Best of 2020)

Editor's note: This article originally appeared May 14, 2020, and is being shared again as part of RheumNow's "Best of 2020".

Best of 2020: Infusions in the Time of Coronavirus

Editor's note: This article originally appeared March 20, 2020, and is being shared again as part of our "Best of 2020" coverage. 

Best of 2020: My Experience as a COVID19 Vaccine Trial Participant

Editor's note: This blog originally appeared December 1, 2020, and is being shared again as part of our "Best of 2020" coverage. 

Best of 2020: The COVID-19 Global Rheumatology Registry

Editor's note: This article originally appeared March 17, 2020 and is being shared again as a "Best of 2020". 

As the highly virulent SARS-CoV-2 spreads over the world, uncertainty and fear for our patients with rheumatic diseases mount.  

Best of 2020: Some Good Things, During the Time of COVID-19

Editor's note: This blog originally appeared April 1, 2020 and is being shared again as a "Best of 2020" wrap up this year. 

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Editor's note: This article originally appeared March 18, 2020, and is being shared again as "Best of 2020" for your reading pleasure.

Ready for Telemedicine/Telerheumatology?

Best of 2020: Rheumatic Disease Drugs and COVID-19

Editor's note: This article originally appeared March 17, 2020, and is being shared again this week as a "Best of 2020" article. Enjoy!

Best of 2020: The Nine Lives of Hydroxychloroquine (Updated)

Editor's note: This article originally appeared May 18, 2020, and is being shared again as a "Best of 2020" article as we wrap up this year. 

ACIP Recommendations for Pfizer-BioNTech COVID-19 Vaccine Use (including Special Populations)

CDC/MMWR

Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years. 

COVID-19 as a Leading Cause of Death in the USA

The exponential rise in deaths from the coronavirus (COVID-19) in the last several months is put into perspective by JAMA Viewpoint article noting that current US death rates of > 3000 per day from COVID-19 is greater than that seen in one day on September 11, 2001 (9/11 attacks, clai

COVID Risks in Systemic Autoimmune Patients

There have been conflicting reports of whether rheumatic patients have greater risks once they are infected with COVID-19. This claims cohort analysis suggests a mixed picture. 

Social

Following a mild bout of COVID-19, Dr. Kathryn Dao, shares insights on the best way to handle mild cases whether it is yourself or a friend/family member who has COVID19. https://t.co/mevbQVNjPp ( @KDAO2011) https://t.co/CSzB9ChH3r
Dr. John Cush @RheumNow ( View Tweet )
2 years 2 months ago
ICYMI: MMWR reports >40,000 pregnant women who received COVID-19 vaccination during pregnancy- VAX not associated with preterm birth or small-for-gestational-age at birth overall compared with unvaccinated pregnant women. https://t.co/GtRMsNrFnn

Dr. John Cush @RheumNow ( View Tweet )

2 years 2 months ago
From 1969 hospitalized COVID Spanish pts (46% F, age 61), 31 pts w/ preexisting RMD -- they did not have more long-term post-COVID sxs (OR 1.46; 0.89–2.4), functional limitation (OR 1.058), anxiety, depression or MSK pain vs non-RMD https://t.co/IYJz5zFoLe

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago
ICYMI: JAMA reports that between Dec 2020 and July 2021, COVID-19 vaccination saved nearly 241,000 lives, prevented 1, 133, 617 hospitalizations and prevented more than 14 million COVID-19 cases (all in 1st 6 mos of the COVID vaccines) https://t.co/q9TvLjtY9p

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago
3rd Vaccine Dose May Benefit ANCA-Associated Vasculitis Patients https://t.co/UXUryaQ7Fz https://t.co/p40xND4lVP
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
How's the United States doing on boosters? Trailing a long list of countries, including Serbia, Slovenia, and Lithuania @OurWorldInData https://t.co/cOCVoyuqT3
Eric Topol @EricTopol ( View Tweet )
2 years 3 months ago
How Bad and How Far? CDC says to date, in the USA, there have been 6,715,937 COVID cases and 850,575 deaths from COVID-19. A total of 249,393,487 (75.1%) have recv at least one VAX dose, 209,312,770 (63%) fully VAX, 38.7% had a booster dose https://t.co/M9fYWL80ae

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago
COVAX Registry: Safety of COVID-19 Vaccines in Rheum Patients  https://t.co/dzDuza09JW https://t.co/HqL7nWdaP0
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
World Health Organization has recommended baricitinib & sotrovimab for COVID-19 (both already given EUA by the FDA). BARI (+/- steroids) given as 4 mg qd to severe hospitalized COVID. Sotrovimab, is for outpt, less severe disease. https://t.co/Hv8YdWUoYk https://t.co/l98zcyfGRk https://t.co/RAHKhqPWjp
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
JAMA reports that between Dec 2020 and July 2021, COVID-19 vaccination saved nearly 241,000 lives, prevented 1, 133, 617 hospitalizations and prevented more than 14 million COVID-19 cases (all in 1st 6 mos of the COVID vaccines) https://t.co/VIcwcPwbjn

Dr. John Cush @RheumNow ( View Tweet )

2 years 3 months ago